Article Link: FDA Approves Octapharma’s Octagam 10% for Adult Dermatomyositis

PARAMUS, N.J.–(BUSINESS WIRE) July 20, 2021 –The U.S. Food and Drug Administration (FDA) has granted approval to Octapharma USA for Octagam® 10% [Immune Globulin Intravenous (Human)], the first and only intravenous immunoglobulin (IVIg) to be…

Source: FDA New Drug Approvals